Cover Image
市場調查報告書

肺鱗狀細胞癌:全球臨床實驗檢討

Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 304743
出版日期 內容資訊 英文 161 Pages
訂單完成後即時交付
價格
Back to Top
肺鱗狀細胞癌:全球臨床實驗檢討 Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014
出版日期: 2014年05月26日 內容資訊: 英文 161 Pages
簡介

本報告提供肺鱗狀細胞癌相關的臨床研究最新趨勢分析,提供疾病·治療方法概要,並彙整臨床實驗的主要國家,G7各國及E7(新興7國)的臨床實驗數及實驗對象採用狀況,地區、PHASE、階段別的進行狀況,有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊。

目錄

簡介

  • 肺鱗狀細胞癌
  • 本報告概要

各地區的臨床實驗情形

各國臨床實驗數量和平均實驗人數

  • 亞太地區前五名國家的臨床實驗數量
  • 歐洲前五名國家的臨床實驗數量
  • 北美主要國家的臨床實驗數量
  • 中東及非洲主要國家的臨床實驗數量
  • 中南美前五名國家的臨床實驗數量

G7各國臨床實驗數量:癌症臨床實驗數量中,肺鱗狀細胞癌的比率

G7各國臨床實驗數量:Phase別

G7各國臨床實驗數量:各進展狀況

E7(新興7個國家)的臨床實驗數量:癌症臨床實驗數量中,肺鱗狀細胞癌的比率

E7(新興7個國家)的Phase別臨床實驗數量

E7(新興7個國家)的各進展狀況臨床實驗數量

Phase別臨床實驗數量

  • 進行中的臨床實驗:不同階段

各進展狀況臨床實驗數量

試驗指標達成狀況別臨床實驗數量

尚未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

有潛力的藥劑

最新臨床實驗資訊

臨床實驗簡介

  • 代表性企業臨床實驗概要
    • F. Hoffmann-La Roche Ltd.
    • Eli Lilly and Company
    • Pfizer Inc.
    • Bristol-Myers Squibb Company
    • AstraZeneca PLC
    • AbbVie Inc.
    • Novartis AG
    • GlaxoSmithKline plc
    • Debiopharm International S.A.
    • Agennix AG
  • 有代表性的研究機關·醫院臨床實驗概要
    • National Cancer Institute
    • Mayo Clinic
    • Cancer Institute Hospital Japanese Foundation for Cancer Research
    • Rigshospitalet
    • Sarah Cannon Research Institute
    • Wake Forest University
    • 廣島大學醫院
    • Eastern Cooperative Oncology Group
    • Samsung Medical Center

5個有代表性的臨床實驗簡介

附錄

圖表一覽

目錄
Product Code: GDHC2164CTIDB

GlobalData's clinical trial report, "Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014" provides data on the Squamous Non-Small Cell Lung Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Squamous Non-Small Cell Lung Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Squamous Non-Small Cell Lung Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Squamous Non-Small Cell Lung Cancer
    • Report Guidance
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
    • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
    • Top Five Countries Contributing to Clinical Trials in Europe
    • Top Countries Contributing to Clinical Trials in North America
    • Top Countries Contributing to Clinical Trials in Middle East and Africa
    • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Squamous Non-Small Cell Lung Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Squamous Non-Small Cell Lung Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Squamous Non-Small Cell Lung Cancer
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Squamous Non-Small Cell Lung Cancer
    • Sep 09, 2013: Oncolytics Biotech Announces Positive Final Tumour Response Data for U.S. Phase 2 Study of REOLYSIN in Squamous Cell Lung Cancer
    • Aug 13, 2013: Eli Lilly and Company's Phase III study of necitumumab meets primary endpoint
    • Jun 04, 2013: Debiopharm Announces Additional Phase I Clinical Trial Evaluating Debio 1143 Combined With Chemotherapies For Patients With Selected Solid Malignancies
    • May 23, 2013: OncoGenex Pharma Announces Plans For Initiation Of Cedar Clinical Trial Evaluating OGX-427 In Combination With Chemotherapy In Advanced Squamous Cell Lung Cancer
    • Mar 28, 2013: Oncolytics Biotech Meets Primary Overall Statistical Endpoint In US Phase II Study Of Reolysin In Squamous Cell Lung Cancer
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • AbbVie Inc.
      • Clinical Trial Overview of AbbVie Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Debiopharm International S.A.
      • Clinical Trial Overview of Debiopharm International S.A.
      • Agennix AG
      • Clinical Trial Overview of Agennix AG
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Mayo Clinic
      • Clinical Trial Overview of Mayo Clinic
      • Cancer Institute Hospital Japanese Foundation for Cancer Research
      • Clinical Trial Overview of Cancer Institute Hospital Japanese Foundation for Cancer Research
      • Rigshospitalet
      • Clinical Trial Overview of Rigshospitalet
      • Sarah Cannon Research Institute
      • Clinical Trial Overview of Sarah Cannon Research Institute
      • Wake Forest University
      • Clinical Trial Overview of Wake Forest University
      • Hiroshima University Hospital
      • Clinical Trial Overview of Hiroshima University Hospital
      • Eastern Cooperative Oncology Group
      • Clinical Trial Overview of Eastern Cooperative Oncology Group
      • Samsung Medical Center
      • Clinical Trial Overview of Samsung Medical Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials by Region, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Squamous Non-Small Cell Lung Cancer to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Squamous Non-Small Cell Lung Cancer to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Squamous Non-Small Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Debiopharm International S.A., 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Agennix AG, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Cancer Institute Hospital Japanese Foundation for Cancer Research, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarah Cannon Research Institute, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Hiroshima University Hospital, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Cooperative Oncology Group, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2014*

List of Figures

  • Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Squamous Non-Small Cell Lung Cancer to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Squamous Non-Small Cell Lung Cancer to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Squamous Non-Small Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top